Trial · NCT01702805
Outcomes30
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 30
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Death or Neurodevelopmental Impairment | Birth to 22-26 months corrected age | The analysis population includes all randomized infants with available data for death and/or neurodevelopmental impairment. | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Death | Birth to 22-26 months corrected age | The analysis population includes all randomized infants with available vital status. | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Neurodevelopmental Impairment | at 22-26 months corrected age | The analysis population includes all randomized infants with available data for neurodevelopmental impairment. | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Cognitive Delay | at 22-26 months corrected age | The analysis population includes all randomized infants with available data at the two-year followup. | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Moderate or Severe Cerebral Palsy | at 22-26 months corrected age | The analysis population includes all randomized infants with available data at the two-year followup. | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Severe Vision Impairment | at 22-26 months corrected age | The analysis population includes all randomized infants with available data at the two-year followup. | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Severe Hearing Impairment | at 22-26 months corrected age | The analysis population includes all randomized infants with available data at the two-year followup. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Survival to Discharge Without Severe Complications | Birth to initial hospital discharge or to death if it occurs earlier (a median of 97 days) | The analysis population includes all randomized infants with available data up to hospital discharge or death. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Bronchopulmonary Dysplasia, Diagnosed on the Basis of the Need for Supplemental Oxygen After a Standardized Oxygen Reduction Test at 36 Weeks of Postmenstrual Age | at 36 weeks postmenstrual age | The analysis population includes all randomized infants with available data at 36 weeks postmenstrual age. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Retinopathy of Prematurity Stage >=3 or Treatment for That Condition Received | Birth to initial hospital discharge or to death if it occurs earlier (a median of 97 days) | The analysis population includes all randomized infants with available data up to hospital discharge or death. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Grade 3 or 4 Intraventricular Hemorrhage, Cystic Periventricular Leukomalacia, or Ventriculomegaly Diagnosed on Ultrasonographic Examination | Birth to initial hospital discharge or to death if it occurs earlier (a median of 97 days) | The analysis population includes all randomized infants with available data up to hospital discharge or death. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Necrotizing Enterocolitis, Bell's Stage >=2 | Birth to initial hospital discharge or to death if it occurs earlier (a median of 97 days) | The analysis population includes all randomized infants with available data up to hospital discharge or death. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Transfusions Per Infant | Birth, up to the earliest of: death, hospital discharge, or 36 weeks postmenstrual age (PMA) | The analysis population includes all randomized infants with available data up to death, hospital discharge, or 36 weeks PMA, whichever occurs first | Transfusions | MEAN |
| SECONDARY | Weight-for-age: Z-score | at 36 weeks postmenstrual age or initial hospital discharge, whichever occurs first | The analysis population includes all randomized infants with available data at 36 weeks postmenstrual age or at initial hospital discharge, whichever occurs first. | Z-score | MEAN |
| SECONDARY | Length-for-age: Z-score | at 36 weeks postmenstrual age or initial hospital discharge, whichever occurs first | The analysis population includes all randomized infants with available data at 36 weeks postmenstrual age or initial hospital discharge, whichever occurs first. | Z-score | MEAN |
| SECONDARY | Head Circumference-for-age: Z-score | at 36 weeks postmenstrual age or initial hospital discharge, whichever occurs first | The analysis population includes all randomized infants with available data at 36 weeks postmenstrual age or at initial hospital discharge, whichever occurs first. | Z-score | MEAN |
| SECONDARY | Postmenstrual Age at Final Trachael Extubation | at final trachael extubation, assessed from birth up to the earliest of: death, hospital discharge, or 36 weeks postmenstrual age | The analysis population includes all randomized infants with available data on trachael extubation. | Weeks | MEAN |
| SECONDARY | Postmenstrual Age at Final Caffeine Dose in Infants Who Received Caffeine Treatment | at final caffeine dose, assessed from birth up to the earliest of: death, hospital discharge, or 36 weeks postmenstrual age | The analysis population includes all randomized infants with available data on caffeine treatment. | Weeks | MEAN |
| SECONDARY | Length of Stay | at initial hospital discharge or at death if it occurs earlier (a median of 97 days) | The analysis population includes all randomized infants with available data up to the initial hospital discharge or death, whichever occurs first. | Days | MEDIAN |
| SECONDARY | Time to Full Enteral Feeding | at first full enteral feeding, assessed from birth up to initial hospital discharge or to death if it occurs earlier (a median of 97 days) | The analysis population includes all randomized infants with available data on enteral feeding. | Days | MEDIAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01702805/outcomes